Sensible‚Äôs Rapid PCR platform is designed to test patients for infectious diseases using PCR technology at the point-of-care. Sensible‚Äôs platform was developed based on pandemic-testing principles. Sensible‚Äôs platform can generate a fully-automated, real-time PCR result in 10 minutes for the same price as a rapid antigen test.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 7
Organization Type: Mid-stage Startup (A or B)
Market Keywords: point-of-care, infectious disease, in-vitro diagnostics